Latest round

Series A

Last raised

May 2019

Total raised

$4.1M

Investors

2

About selectION

selectION, Inc. is a biotechnology firm focused on innovative pharmaceuticals that treat autoimmune diseases and disorders related to ion channels.Founded in 2017 and headquartered in San Diego, US, selectION, Inc. specializes in therapeutic solutions for autoimmune conditions.selectION, Inc. focuses on developing innovative pharmaceuticals aimed at treating autoimmune diseases and disorders related to ion channels.3 ion channel blocker that specifically targets T-cell mediated autoimmunity while preserving patients’ full immunocompetence. This product is designed to improve the quality of life for individuals suffering from conditions such as psoriasis vulgaris and psoriatic arthritis. Currently, selectION serves a diverse clientele which includes healthcare providers and research institutions across North America and Europe, specifically in the United States and Germany.selectION, Inc. generates revenue primarily through partnerships and clinical collaborations in the biopharmaceutical sector. The company engages in B2B transactions, collaborating with healthcare institutions and research organizations to deliver its flagship product, si-544. Specific pricing plans for their products and services are tailored to the needs of their partners, reflecting the bespoke nature of biopharmaceutical transactions.selectION, Inc. is focused on expanding its product line, with plans to launch new therapeutics targeting additional autoimmune conditions in the coming years.06 mn to support these initiatives. Additionally, funds will be directed towards enhancing clinical trials and developing strategic partnerships that can further bolster its competitive position in the biopharmaceutical industry.

Who invested in selectION

2 investors across 1 round

See all investors in selectION

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 31, 2019

    Amount

    $4.1M

    Investors

    Locked

Questions about selectION

Who invested in selectION?

selectION has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has selectION raised?

selectION has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did selectION last raise money?

selectION's most recent round on record is a Series A, in May 2019.

What does selectION do?

selectION is a pharmaceuticals company.

Where is selectION headquartered?

selectION is headquartered in San Diego, US.

Which VCs invest in companies like selectION?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at selectION's stage. Their profiles are linked below.

Raising like selectION? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.